Sigilon Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sigilon Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 35% to $12,944,000. The net income raised on -$43,456,000 and profit margin reached -336%. Total operating expenses were $56,610,000.
Profit Margin
| 2018 | 4.63M | -22.76M | -490.94% |
|---|---|---|---|
| 2019 | 14.15M | -44.56M | -314.86% |
| 2020 | 13.37M | -54.86M | -410.25% |
| 2021 | 9.59M | -78.23M | -815.04% |
| 2022 | 12.94M | -43.45M | -335.72% |
SGTX Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 12.94M | 9.59M | 13.37M | 14.15M | 4.63M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 12.94M | 9.59M | 13.37M | 14.15M | 4.63M |
Operating exp. | |||||
Research and development | 37.63M | 65.06M | 53.48M | 48.10M | 21.03M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 56.61M | 85.23M | 66.01M | 58.27M | 27.71M |
Operating income | -43.66M | -75.63M | -52.64M | -44.12M | -23.07M |
Other income (expenses), net | 105K | -1.67M | -1.96M | 198K | -99K |
Income before tax | -43.56M | -77.31M | -54.60M | -43.92M | -22.76M |
Income tax expense | -105K | 925K | 259K | 644K | 599K |
Net income | -43.45M | -78.23M | -54.86M | -44.56M | -22.76M |
Earnings per share | |||||
Basic EPS | -1.34 | -31.92 | -22.67 | -27.53 | -18.85 |
Diluted EPS | -1.34 | -31.92 | -22.67 | -27.53 | -18.85 |
| Data source | Data source | Data source |